Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GENTEX CORPGNTX · Entity 3954 | Chief Technology Officer | February 17, 2026 | February 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GENTEX CORP
Report date February 17, 2026 · Filed February 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 87,967 |
Reported balance
After 2026-02-17 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-02-17 · Grant · Acquired 31,993 · Balance 87,967 F1: 31,993 shares are performance-based shares where the total number of shares granted were based on long term performance incentives. F2: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan |
| Common StockSEC Table I · non-derivative | Direct | 73,807 |
Reported balance
After 2026-02-17 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-02-17 · Tax withholding · Disposed 14,160 · Balance 73,807 |
| Common StockSEC Table I · non-derivative | Direct | 64,891 |
Reported balance
After 2026-02-17 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-02-17 · Sale · Disposed 8,916 · Balance 64,891 |
| Common StockSEC Table I · non-derivative | Direct | 61,283 |
Reported balance
After 2026-02-17 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-02-17 · Tax withholding · Disposed 3,608 · Balance 61,283 |
| Common StockSEC Table I · non-derivative | Direct | 58,951 |
Reported balance
After 2026-02-17 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2026-02-17 · Sale · Disposed 2,332 · Balance 58,951 |
| Common StockSEC Table I · non-derivative | Direct | 73,904 |
Reported balance
After 2026-02-19 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2026-02-19 · Grant · Acquired 14,953 · Balance 73,904 F3: These shares vest 100% three years from grant award date. |
Filing footnotes · ownership attribution and instrument terms
F1: 31,993 shares are performance-based shares where the total number of shares granted were based on long term performance incentives.
F2: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan
F3: These shares vest 100% three years from grant award date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 28, 2018 Filed Dec 31, 2018 19:25 UTC | GENTEX CORP GNTX · Entity 3954 | PurchaseCommon Stock | 19 | $16.86 | $320.34 |
DisclosureSEC source: 0001562180-18-005127 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,432 F1 · kind: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| September 28, 2018 Filed Oct 1, 2018 17:26 UTC | GENTEX CORP GNTX · Entity 3954 | PurchaseCommon Stock | 18 | $18.24 | $328.32 |
DisclosureSEC source: 0001562180-18-004058 · primarydocument.xml · nonDerivative · entry 2 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,413 F2 · kind: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| September 27, 2018 Filed Oct 1, 2018 17:26 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 4,000 | $21.50 | $85,999.20 |
DisclosureSEC source: 0001562180-18-004058 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,395 F1 · price: This transaction was executed in multiple trades at prices ranging from $21.30 to $21.66. The price reported above reflects the weighted average price. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 00:24 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 16 | $19.57 | $313.12 |
DisclosureSEC source: 0001562180-18-003179 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,395 F1 · price: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 22:14 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 17 | $19.57 | $332.69 |
DisclosureSEC source: 0001562180-18-001771 · primarydocument.xml · nonDerivative · entry 1 Boehm Neil · CIK 0001731934 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,379 F1 · price: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.